COVID-19 Seroprevalence in Canada Modelling Waning and Boosting COVID-19 Immunity in Canada a Canadian Immunization Research Network Study

COVID-19 seroprevalence changes over time, with infection, vaccination, and waning immunity. Seroprevalence estimates are needed to determine when increased COVID-19 vaccination coverage is needed, and when booster doses should be considered, to reduce the spread and disease severity of COVID-19 inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Dick, David W., Childs, Lauren, Feng, Zhilan, Li, Jing, Röst, Gergely, Buckeridge, David L., Ogden, Nick H., Heffernan, Jane M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779812/
https://www.ncbi.nlm.nih.gov/pubmed/35062678
http://dx.doi.org/10.3390/vaccines10010017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779812/
https://www.ncbi.nlm.nih.gov/pubmed/35062678
http://dx.doi.org/10.3390/vaccines10010017

Ejemplares similares